Tadashi Arai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tadashi Arai has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Kimura
Japan Atomic Energy Research Institute
1 shared publication - Kotaro Oyama
Takasaki Institute for Advanced Quantum Science, National Institutes for Quantum Science and Technology, Gunma, Japan
1 shared publication - Miho Ueno
Takasaki Advanced Radiation Research Institute (TARRI), National Institutes for Quantum Science and Technology (QST), 1233 Watanuki-Machi, Takasaki 370-1207, Gunma, Japan
1 shared publication - Mitsumasa Taguchi
Takasaki Institute for Advanced Quantum Science National Institutes for Quantum Science and Technology (QST) Takasaki Gunma Japan
1 shared publication
Latest Publications
- Open Access
- 12 March 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (3) , 714
Radiation Crosslinked Smart Peptide Nanoparticles: A New Platform for Tumor Imaging
Nanoparticles have been employed to develop nanosensors and drug carriers that accumulate in tumors. Thus, it is necessary to control the particle size, surface potential, and biodegradability of these nanoparticles for effective tumor accumulation and safe medical application. In this study, to form a nanoparticle platform suitable for diagnostic and drug delivery system (DDS) applications, peptides composed of aromatic amino acid residues were designed and synthesized based on the radiation crosslinking mechanism of proteins. The peptide nanoparticles, which were produced by γ-ray irradiation, displayed a positive surface potential, maintained biodegradability, and were stable in water and phosphoric buffer solution during actual diagnosis. The surface potential of the peptide nanoparticles could be changed to negative by using a fluorescent labeling reagent, so that the fluorescent-labeled peptide nanoparticles were uptaken by HeLa cells. The radiation-crosslinked nanoparticles can be applied as a platform for tumor-targeting diagnostics and DDS therapy.
- 12 March 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (3) , 714
Open AccessRadiation Crosslinked Smart Peptide Nanoparticles: A New Platform for Tumor Imaging
Nanoparticles have been employed to develop nanosensors and drug carriers that accumulate in tumors. Thus, it is necessary to control the particle size, surface potential, and biodegradability of these nanoparticles for effective tumor accumulation and safe medical application. In this study, to form a nanoparticle platform suitable for diagnostic and drug delivery system (DDS) applications, peptides composed of aromatic amino acid residues were designed and synthesized based on the radiation crosslinking mechanism of proteins. The peptide nanoparticles, which were produced by γ-ray irradiation, displayed a positive surface potential, maintained biodegradability, and were stable in water and phosphoric buffer solution during actual diagnosis. The surface potential of the peptide nanoparticles could be changed to negative by using a fluorescent labeling reagent, so that the fluorescent-labeled peptide nanoparticles were uptaken by HeLa cells. The radiation-crosslinked nanoparticles can be applied as a platform for tumor-targeting diagnostics and DDS therapy.